155 related articles for article (PubMed ID: 10966568)
1. Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas.
Dai Y; Morishita Y; Mase K; Sato N; Akaogi E; Mitsui T; Noguchi M
Cancer; 2000 Aug; 90(4):258-63. PubMed ID: 10966568
[TBL] [Abstract][Full Text] [Related]
2. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
3. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.
Keohavong P; Gao WM; Zheng KC; Mady H; Lan Q; Melhem M; Mumford J
Anal Biochem; 2004 Jan; 324(1):92-9. PubMed ID: 14654050
[TBL] [Abstract][Full Text] [Related]
4. K-ras and rho A mutations in malignant pleural effusion.
Nakamoto M; Teramoto H; Matsumoto S; Igishi T; Shimizu E
Int J Oncol; 2001 Nov; 19(5):971-6. PubMed ID: 11604996
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
[TBL] [Abstract][Full Text] [Related]
6. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
7. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
Sarkar FH; Li Y; Vallyathan V
Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
[TBL] [Abstract][Full Text] [Related]
9. K-ras genotypes and prognosis in non-small-cell lung cancer.
Rosell R; Monzo M; Molina F; Martinez E; Pifarre A; Moreno I; Mate JL; de Anta JM; Sanchez M; Font A
Ann Oncol; 1995; 6 Suppl 3():S15-20. PubMed ID: 8616107
[TBL] [Abstract][Full Text] [Related]
10. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination.
Yamashita K; Kuba T; Shinoda H; Takahashi E; Okayasu I
Am J Clin Pathol; 1998 Jun; 109(6):704-11. PubMed ID: 9620027
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.
Ahrendt SA; Chow JT; Xu LH; Yang SC; Eisenberger CF; Esteller M; Herman JG; Wu L; Decker PA; Jen J; Sidransky D
J Natl Cancer Inst; 1999 Feb; 91(4):332-9. PubMed ID: 10050866
[TBL] [Abstract][Full Text] [Related]
13. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.
Sun PL; Jin Y; Kim H; Lee CT; Jheon S; Chung JH
Cancer Cytopathol; 2013 Jun; 121(6):311-9. PubMed ID: 23225576
[TBL] [Abstract][Full Text] [Related]
14. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
15. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion.
Li J; Bao QL; Wang Y; Hu YM; Chen P
Cancer Biomark; 2013; 13(1):49-58. PubMed ID: 23736021
[TBL] [Abstract][Full Text] [Related]
18. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer.
Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z
Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089
[TBL] [Abstract][Full Text] [Related]
19. Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma.
Chen JT; Ho WL; Cheng YW; Lee H
Anticancer Res; 2000; 20(4):2687-90. PubMed ID: 10953344
[TBL] [Abstract][Full Text] [Related]
20. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]